As far as overall prognosis is concerned there is the prospect of continuing lengthening of survival, especially using newer targeted therapies.
The prognosis of glioblastoma continues to be dismal in spite of progress made in the molecular characterisation of the most frequent genetic alterations of the disease (Parsons et al, 2008).
Since loss of hERα expression is associated with poor prognosis and continued expression of hERα is associated with disease-free survival and correlates well with tumor differentiation state, we wanted to investigate the regulation of nmt55/p54nrb expression.
His well-intentioned hospital and doctors, fully aware of his dismal prognosis, continued the excruciating process of inserting pencil-thick IV catheters and cleaning fist-size bed sores.
However, much can be done to improve QoL by early diagnosis of MD with good communication of prognosis and continuing support.
Despite the progress made in the molecular aspects of malignant gliomas, the prognosis of brain tumors continues to be dismal.
Despite intensive multi-modality treatment including tumor resection, post-operative radiotherapy and frequently adjuvant chemotherapy, the prognosis of malignant glioma continues to be poor.
The staging and prognosis of cutaneous melanoma continue to be refined; the most recent version was published as 2009 (7th edition) AJCC melanoma staging system.
Despite the use of platinum-based combination chemotherapy, which has shown to prolong survival in patients with advanced non-small-cell-lung cancer (NSCLC) when compared to best supportive care, the prognosis of advanced NSCLC continues to be poor with a median survival of about 10 months [ 1, 2].
Despite a very severe initial clinical presentation, it is remarkable to observe an acceptable rate of death and frequent acceptable functional prognosis, which continues to improve after 1 year, as opposed to arterial brain ischemia.
